BioMedNewsBreaks – InMed Pharmaceuticals Inc (NASDAQ: INM) Approves Election of Directors During 2023 Annual General Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
InMed Announces Results of 2023 Annual General Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
InMed Pharmaceuticals Inc. , a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today confirmed that, at its annual general meeting.
Form 10-K InMed Pharmaceuticals For: Jun 30 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
16.12.2022 - VANCOUVER, British Columbia, Dec. 15, 2022 (GLOBE NEWSWIRE) - InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, .